Stock listing
Aeolus Pharmaceuticals Inc
Selected listing: AOLS · OTC · USD · US
Aeolus Pharmaceuticals Inc (OTC:AOLS), Health Technology. Latest release Mar 23, 2018: Aeolus Announces Commencement of Assignment for the Benefit of Creditors.
- Ticker
- OTC:AOLS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Aeolus Pharmaceuticals Inc
The company focuses on developing innovative pharmaceutical solutions. Investors can find information about its operations and market activities on its dedicated public company page.
Latest news from Aeolus Pharmaceuticals Inc
Aeolus Announces Commencement of Assignment for the Benefit of Creditors
March 22, 2018
Aeolus Announces Presentation of Pharmacometric Analysis Confirming Statistically Significant Improvement in Survival 6 Months After Exposure to Lethal Thoracic Radiation Following Treatment with AEOL 10150
September 25, 2017
Aeolus Announces Presentation of Pharmacometric Analysis of Data Establishing Optimal Dose Schedule of AEOL 10150 for Treatment of Lung Radiation Damage
September 21, 2017
Aeolus Announces Publication of Data Demonstrating that Adding AEOL 10150 to Standard Therapy After Nerve Agent Exposure Improves Survival and Reduces Brain Damage and Nerve Inflammation in Rats
September 19, 2017
AEOLUS' AEOL 10150 is Safe and Well Tolerated in Phase 1 Study in Healthy Subjects
September 17, 2017
Research Aeolus Pharmaceuticals Inc
Aeolus Pharmaceuticals Inc company profile
View the public company page for Aeolus Pharmaceuticals Inc on 6ix.
Aeolus Pharmaceuticals Inc news
Read company news and market updates connected to Aeolus Pharmaceuticals Inc.
Aeolus Pharmaceuticals Inc investor events
Find investor webinars, events, and replay context for Aeolus Pharmaceuticals Inc.